 Kristen DeSanto
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acupuncture Therapy | 2 | 2023 | 18 | 1.710 |
Why?
| | Myofascial Pain Syndromes | 2 | 2023 | 13 | 1.710 |
Why?
| | Low Back Pain | 2 | 2023 | 95 | 1.550 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 299 | 1.180 |
Why?
| | Patient Education as Topic | 2 | 2022 | 678 | 1.010 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2023 | 3 | 0.910 |
Why?
| | Nutrition Therapy | 1 | 2023 | 31 | 0.880 |
Why?
| | Fibromyalgia | 1 | 2023 | 56 | 0.850 |
Why?
| | Naltrexone | 1 | 2023 | 83 | 0.830 |
Why?
| | Postmenopause | 1 | 2023 | 303 | 0.750 |
Why?
| | Hallucinogens | 1 | 2022 | 73 | 0.740 |
Why?
| | Water Sports | 1 | 2020 | 1 | 0.740 |
Why?
| | Analgesics | 2 | 2022 | 158 | 0.720 |
Why?
| | Wound Healing | 1 | 2022 | 258 | 0.710 |
Why?
| | Antipsychotic Agents | 1 | 2022 | 184 | 0.710 |
Why?
| | Behavior Therapy | 1 | 2022 | 226 | 0.700 |
Why?
| | Ganglion Cysts | 1 | 2020 | 10 | 0.680 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 350 | 0.680 |
Why?
| | Carcinoma, Basal Cell | 1 | 2020 | 68 | 0.670 |
Why?
| | Wrist | 1 | 2020 | 48 | 0.670 |
Why?
| | Spironolactone | 1 | 2019 | 28 | 0.650 |
Why?
| | Memory | 1 | 2021 | 209 | 0.650 |
Why?
| | Diuretics | 1 | 2019 | 66 | 0.650 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 273 | 0.640 |
Why?
| | Communication | 3 | 2021 | 747 | 0.630 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2096 | 0.620 |
Why?
| | Clostridium Infections | 1 | 2019 | 56 | 0.620 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 96 | 0.610 |
Why?
| | Glycemic Index | 1 | 2018 | 21 | 0.600 |
Why?
| | Viscosupplements | 1 | 2018 | 10 | 0.600 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 106 | 0.600 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 141 | 0.580 |
Why?
| | Musculoskeletal System | 1 | 2018 | 43 | 0.580 |
Why?
| | Humans | 47 | 2024 | 114925 | 0.580 |
Why?
| | Testosterone | 1 | 2021 | 343 | 0.580 |
Why?
| | Sleep | 1 | 2022 | 632 | 0.560 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2024 | 1215 | 0.560 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 234 | 0.540 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 189 | 0.520 |
Why?
| | Chagas Disease | 3 | 2021 | 34 | 0.520 |
Why?
| | Cannabis | 1 | 2022 | 384 | 0.520 |
Why?
| | Pain Measurement | 3 | 2023 | 446 | 0.490 |
Why?
| | Osteoarthritis, Knee | 1 | 2018 | 213 | 0.480 |
Why?
| | Athletic Injuries | 1 | 2020 | 456 | 0.470 |
Why?
| | Glucocorticoids | 1 | 2018 | 534 | 0.440 |
Why?
| | Skin Neoplasms | 1 | 2020 | 762 | 0.430 |
Why?
| | Health Promotion | 1 | 2018 | 686 | 0.390 |
Why?
| | Palliative Care | 4 | 2024 | 639 | 0.390 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 77 | 0.380 |
Why?
| | Hypertension | 1 | 2019 | 1059 | 0.370 |
Why?
| | Asthma | 1 | 2023 | 2042 | 0.370 |
Why?
| | Pain Management | 2 | 2023 | 289 | 0.300 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1729 | 0.300 |
Why?
| | Cardiomyopathies | 2 | 2021 | 300 | 0.290 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 388 | 0.290 |
Why?
| | Advance Care Planning | 2 | 2021 | 197 | 0.280 |
Why?
| | Sepsis | 2 | 2022 | 508 | 0.260 |
Why?
| | Population Groups | 2 | 2021 | 57 | 0.230 |
Why?
| | Milk Hypersensitivity | 1 | 2024 | 22 | 0.230 |
Why?
| | Muscle Cramp | 1 | 2023 | 7 | 0.230 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 40 | 0.230 |
Why?
| | Live Birth | 1 | 2024 | 48 | 0.230 |
Why?
| | Egg Hypersensitivity | 1 | 2024 | 45 | 0.220 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.220 |
Why?
| | Preconception Care | 1 | 2024 | 31 | 0.220 |
Why?
| | Amitriptyline | 1 | 2023 | 21 | 0.220 |
Why?
| | Trigger Points | 1 | 2023 | 14 | 0.220 |
Why?
| | Magnesium | 1 | 2023 | 145 | 0.220 |
Why?
| | Stroke | 2 | 2022 | 1019 | 0.210 |
Why?
| | Urogenital Abnormalities | 1 | 2023 | 48 | 0.210 |
Why?
| | Fertility | 1 | 2024 | 130 | 0.210 |
Why?
| | Desensitization, Immunologic | 1 | 2024 | 117 | 0.210 |
Why?
| | Quetiapine Fumarate | 1 | 2022 | 22 | 0.210 |
Why?
| | Transition to Adult Care | 1 | 2023 | 63 | 0.210 |
Why?
| | Rectum | 1 | 2023 | 153 | 0.210 |
Why?
| | Aripiprazole | 1 | 2022 | 17 | 0.210 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6363 | 0.200 |
Why?
| | Leg | 1 | 2023 | 225 | 0.200 |
Why?
| | Administration, Inhalation | 1 | 2023 | 642 | 0.200 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1400 | 0.200 |
Why?
| | Colon | 1 | 2023 | 233 | 0.190 |
Why?
| | Chagas Cardiomyopathy | 1 | 2021 | 22 | 0.190 |
Why?
| | Benzodiazepines | 1 | 2022 | 116 | 0.190 |
Why?
| | Insulin, Isophane | 1 | 2021 | 17 | 0.190 |
Why?
| | Back Injuries | 1 | 2020 | 5 | 0.180 |
Why?
| | Dermoscopy | 1 | 2020 | 9 | 0.180 |
Why?
| | Drowning | 1 | 2020 | 7 | 0.180 |
Why?
| | Insulin Glargine | 1 | 2021 | 73 | 0.180 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 954 | 0.180 |
Why?
| | Facial Injuries | 1 | 2020 | 19 | 0.180 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 138 | 0.180 |
Why?
| | Transgender Persons | 1 | 2023 | 134 | 0.180 |
Why?
| | Torso | 1 | 2020 | 30 | 0.180 |
Why?
| | Neck Injuries | 1 | 2020 | 18 | 0.180 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1134 | 0.180 |
Why?
| | Nurse's Role | 1 | 2021 | 106 | 0.180 |
Why?
| | Health Information Exchange | 1 | 2020 | 12 | 0.180 |
Why?
| | Attitude to Computers | 1 | 2020 | 27 | 0.180 |
Why?
| | Patient Selection | 1 | 2024 | 642 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 499 | 0.170 |
Why?
| | Dietary Supplements | 1 | 2023 | 458 | 0.170 |
Why?
| | Ambulances | 1 | 2020 | 50 | 0.170 |
Why?
| | Bone and Bones | 1 | 2022 | 278 | 0.170 |
Why?
| | Wearable Electronic Devices | 1 | 2020 | 34 | 0.170 |
Why?
| | Pelvis | 1 | 2020 | 90 | 0.170 |
Why?
| | Upper Extremity | 1 | 2020 | 84 | 0.170 |
Why?
| | Intrauterine Devices | 1 | 2019 | 24 | 0.170 |
Why?
| | Shock, Septic | 1 | 2021 | 185 | 0.170 |
Why?
| | Teaching | 1 | 2021 | 223 | 0.170 |
Why?
| | Weight Loss | 1 | 2024 | 642 | 0.160 |
Why?
| | Female | 13 | 2024 | 59571 | 0.160 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 128 | 0.160 |
Why?
| | Colonoscopy | 1 | 2021 | 205 | 0.160 |
Why?
| | Long-Term Care | 1 | 2019 | 77 | 0.160 |
Why?
| | Volunteers | 1 | 2018 | 31 | 0.150 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 129 | 0.150 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 162 | 0.150 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 43 | 0.150 |
Why?
| | Visual Analog Scale | 1 | 2018 | 31 | 0.150 |
Why?
| | Pain | 1 | 2023 | 710 | 0.150 |
Why?
| | Cytokines | 2 | 2022 | 1843 | 0.150 |
Why?
| | Terminal Care | 1 | 2021 | 213 | 0.150 |
Why?
| | Cooperative Behavior | 1 | 2020 | 383 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 339 | 0.150 |
Why?
| | Lower Extremity | 1 | 2020 | 335 | 0.140 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 718 | 0.140 |
Why?
| | Recurrence | 1 | 2020 | 937 | 0.140 |
Why?
| | Library Services | 1 | 2016 | 8 | 0.140 |
Why?
| | Libraries, Medical | 1 | 2016 | 9 | 0.140 |
Why?
| | Cryptococcus | 1 | 2016 | 8 | 0.140 |
Why?
| | Hypoglycemia | 1 | 2021 | 386 | 0.140 |
Why?
| | Prevalence | 2 | 2021 | 2251 | 0.140 |
Why?
| | Antigens, Fungal | 1 | 2016 | 25 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 928 | 0.130 |
Why?
| | Meningitis, Cryptococcal | 1 | 2016 | 28 | 0.130 |
Why?
| | Vomiting | 1 | 2016 | 124 | 0.130 |
Why?
| | Skin | 1 | 2020 | 659 | 0.130 |
Why?
| | Perception | 1 | 2018 | 310 | 0.130 |
Why?
| | Hospice Care | 1 | 2019 | 185 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1220 | 0.130 |
Why?
| | Administration, Oral | 1 | 2018 | 731 | 0.130 |
Why?
| | Ultrasonography | 1 | 2019 | 633 | 0.130 |
Why?
| | Prognosis | 2 | 2022 | 3344 | 0.120 |
Why?
| | Aged | 5 | 2021 | 19120 | 0.120 |
Why?
| | Acute Disease | 1 | 2018 | 915 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2022 | 587 | 0.120 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 675 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1856 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 621 | 0.120 |
Why?
| | Critical Illness | 1 | 2019 | 643 | 0.120 |
Why?
| | Depression | 1 | 2022 | 1133 | 0.110 |
Why?
| | Risk Assessment | 2 | 2021 | 2975 | 0.110 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 546 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 904 | 0.110 |
Why?
| | Adult | 8 | 2024 | 30604 | 0.110 |
Why?
| | Blood Glucose | 1 | 2022 | 1821 | 0.110 |
Why?
| | Risk Factors | 3 | 2021 | 8637 | 0.100 |
Why?
| | United States | 4 | 2021 | 12209 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2019 | 723 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1813 | 0.100 |
Why?
| | Child | 4 | 2024 | 18362 | 0.100 |
Why?
| | Male | 8 | 2021 | 55655 | 0.090 |
Why?
| | Infant | 1 | 2022 | 7936 | 0.080 |
Why?
| | Middle Aged | 5 | 2021 | 26801 | 0.080 |
Why?
| | Treatment Outcome | 4 | 2024 | 9105 | 0.080 |
Why?
| | Lung | 1 | 2019 | 3593 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1952 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1801 | 0.060 |
Why?
| | Qualitative Research | 2 | 2021 | 936 | 0.060 |
Why?
| | Research Design | 2 | 2021 | 932 | 0.060 |
Why?
| | Eggs | 1 | 2024 | 30 | 0.060 |
Why?
| | Incidence | 2 | 2021 | 2316 | 0.060 |
Why?
| | Cooking | 1 | 2024 | 48 | 0.060 |
Why?
| | Pregnancy Rate | 1 | 2024 | 55 | 0.060 |
Why?
| | Milk | 1 | 2024 | 124 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 90 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 94 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 101 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2024 | 328 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2022 | 197 | 0.050 |
Why?
| | Allergens | 1 | 2024 | 417 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 161 | 0.050 |
Why?
| | Technology | 1 | 2021 | 79 | 0.050 |
Why?
| | Canada | 1 | 2021 | 322 | 0.050 |
Why?
| | Uncertainty | 1 | 2021 | 95 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2021 | 133 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 642 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 225 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 17826 | 0.040 |
Why?
| | Late Onset Disorders | 1 | 2019 | 2 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 325 | 0.040 |
Why?
| | Triage | 1 | 2022 | 192 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 448 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 360 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 90 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2023 | 440 | 0.040 |
Why?
| | Stroke Volume | 1 | 2021 | 510 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 468 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 279 | 0.040 |
Why?
| | Health Education | 1 | 2021 | 322 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 139 | 0.040 |
Why?
| | Kidney | 1 | 2023 | 1184 | 0.030 |
Why?
| | Health Information Management | 1 | 2016 | 7 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 562 | 0.030 |
Why?
| | Lepidoptera | 1 | 1975 | 7 | 0.030 |
Why?
| | Aminopeptidases | 1 | 1975 | 11 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 171 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 336 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1593 | 0.030 |
Why?
| | Moths | 1 | 1975 | 35 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 574 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 10476 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12543 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 196 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2016 | 212 | 0.030 |
Why?
| | Animals | 3 | 2024 | 31837 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2382 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1355 | 0.030 |
Why?
| | Pregnancy | 1 | 2024 | 5525 | 0.030 |
Why?
| | Inflammation | 1 | 2022 | 2485 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 2514 | 0.020 |
Why?
| | Biomedical Research | 1 | 2016 | 585 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3008 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4634 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4089 | 0.020 |
Why?
| | Digitoxin | 1 | 1975 | 4 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 1975 | 57 | 0.020 |
Why?
| | Mercury | 1 | 1975 | 29 | 0.010 |
Why?
| | Molecular Weight | 1 | 1975 | 332 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1975 | 319 | 0.010 |
Why?
| | Copper | 1 | 1975 | 100 | 0.010 |
Why?
| | Larva | 1 | 1975 | 194 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1975 | 512 | 0.010 |
Why?
| | Oligopeptides | 1 | 1975 | 235 | 0.010 |
Why?
| | Zinc | 1 | 1975 | 257 | 0.010 |
Why?
| | Kinetics | 1 | 1975 | 1555 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 449 | 0.010 |
Why?
| | Digitoxigenin | 1 | 1975 | 2 | 0.000 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 25 | 0.000 |
Why?
| | Hydroxylation | 1 | 1975 | 29 | 0.000 |
Why?
| | NADP | 1 | 1975 | 43 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1975 | 1034 | 0.000 |
Why?
| | Rats | 1 | 1975 | 4963 | 0.000 |
Why?
| | Time Factors | 1 | 1975 | 6125 | 0.000 |
Why?
|
|
DeSanto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|